Sign in
4

Changes in Ownership

NextCure, Inc. Filed Acc 0000905148-22-000160

Options or other derivatives

  • President & CEO acquired 262,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Richman Michael · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-31 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +262,400 262,400 D
Loading xslF345X03/form4.xml…